ResearcherFujian Medical UniversityActive in the last 2 years

Shiyun Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1615-1036; OpenAlex author ID A5073226233. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 2 papers

Papers 2

Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circulating immune traits. Co-author DOI 10.1016/j.tranon.2026.103040 ↗
Exosome‐Associated miR‐21‐5p Promotes Pancreatic Cancer Progression Via ABCD2 Last author DOI 10.1155/ijcp/7862846 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ronggui Lin · 1 shared paper, 2026 · strength 0.36
- Paper Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circ… DOI 10.1016/j.tranon.2026.103040 ↗
Fen Lin · 1 shared paper, 2026 · strength 0.36
- Paper Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circ… DOI 10.1016/j.tranon.2026.103040 ↗
Zongqi Weng · 1 shared paper, 2026 · strength 0.36
- Paper Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circ… DOI 10.1016/j.tranon.2026.103040 ↗
Ming Zhou · 1 shared paper, 2026 · strength 0.33
- Paper Exosome‐Associated miR‐21‐5p Promotes Pancreatic Cancer Progression Via ABCD2 DOI 10.1155/ijcp/7862846 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.